LAB Total Utang marang Modal fluidigm.com

LAB (Fluidigm) - tandha merek perusahaan

The debt-to-equity ratio reflects the financial standing of Standard BioTools Inc. (LAB), where the value remains around 0.05. This results from cost optimization and synergies following the asset merger. Standard BioTools Inc. (LAB) is creating a unique cellular analysis environment through cytometry, while simultaneously implementing eco-production standards and reducing harmful emissions within its diagnostic complexes.

LAB: Total Utang marang Modal Standard BioTools 28.04.2023 - 27.10.2026

Rincian metrik komprehensif lan analitis Standard BioTools Corp (LAB)

- rega lan prakiraan konsensus rega:
Rega saham Standard BioTools|LAB - Rata-rata rega prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Standard BioTools|LAB - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Standard BioTools|LAB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku fluidigm.com|LAB - Total Aset Bisnis
- data utang lan likuiditas:
Total Utang marang Modal Standard BioTools Inc.|LAB - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Standard BioTools Inc.|LAB - Utang perusahaan|Utang marang nilai buku Standard BioTools
Analisis komprehensif perusahaan:Standard BioTools LAB
Produk dadi Standard BioTools Inc.

Scaling the delivery of proteomic analysis systems for Standard BioTools Inc. (LAB) requires precise management of borrowed capital. This metric is calculated as the ratio of total liabilities to equity, determining the degree of financial leverage. It serves as a stress test for the model's resilience against external shocks and liquidity risk. The stability of the organization's total debt-to-equity ratio confirms a balance between expansion and solvency. This chart's dynamics allow for an assessment of the efficiency of the debt load.

Pesaing wigati

Total Utang marang Modal A (Agilent)|Utang marang Modal Quest Diagnostics Inc.|Total Utang marang Modal Illumina Corp ILMN|Rasio Utang marang Ekuitas Exact Sciences Inc. (EXAS)|Total Utang marang Modal RVTY (Revvity, Inc.)|bio-rad.com - Total Utang marang Modal|Anbio (NNNN) - Utang marang Ekuitas|SHC - Rasio Utang marang Ekuitas|QDEL: Total Utang marang Modal|OPK (OPKO Health Corp.) - Total Utang marang Modal|Utang marang Ekuitas CareDx Inc|Utang marang Ekuitas maravai.com (MRVI)|Fulgent Genetics - Rasio Total Utang marang Ekuitas|Utang marang Modal CTKB (Cytek Biosciences Inc)|Utang marang Ekuitas OSUR|Koefisien Total Utang marang Modal Exagen Inc XGN|Total Utang marang Modal MDXH (MDxHealth SA)|LUCD: Koefisien Total Utang marang Modal|prenetics.com - Utang marang Ekuitas|IMDX (Insight Molecular Diagnostics Inc) - Koefisien Total Utang marang Modal|TRIB: Utang marang Ekuitas|Koefisien Total Utang marang Modal ProPhase Labs Corp (PRPH)|Rasio Total Utang marang Ekuitas Ainos, Inc.|Utang Agregat marang Modal codiagnostics.com (CODX)|Total Utang marang Modal HSCS (HeartSciences)|Biomerica Inc. - Total Utang marang Modal|Cardio Diagnostics Holdings, Inc. (CDIO) - Utang marang Ekuitas|VRAX - Rasio Utang marang Ekuitas|Total Utang marang Modal Bluejay Diagnostics|aspirawh.com (AWH) - Rasio Utang marang Ekuitas|AXDX (Accelerate Diagnostics, Inc.) - Total Utang marang Modal|Total Utang marang Modal CNTG|Enzo Biochem, Inc. (ENZ) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi fresh2.co (FRES)|GENE - Total Utang marang Modal|ME - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Psychemedics Corporation (PMD)